New hope for tough prostate cancer: early trial of ACE-232 begins
NCT ID NCT06801236
First seen Jan 04, 2026 · Last updated May 14, 2026 · Updated 13 times
Summary
This early-phase study tests a new drug called ACE-232 in about 67 men with a hard-to-treat type of advanced prostate cancer (metastatic castration-resistant prostate cancer). The main goals are to check the drug's safety, find the best dose, and see early signs it might help control the cancer. Participants must have already tried other standard treatments without success.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER (ADENOCARCINOMA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Carolina Urologic Research Center
RECRUITINGMyrtle Beach, South Carolina, 29572, United States
-
Fred Hutchinson Cancer Research Center
RECRUITINGSeattle, Washington, 98109, United States
-
Harvard Medical School-Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
-
M Health Fairview Clinics and Surgery Center
RECRUITINGMinneapolis, Minnesota, 55455, United States
-
Moffitt Cancer Center, Tampa
RECRUITINGTampa, Florida, 33612, United States
-
University of California San Diego, Moores Cancer Center
RECRUITINGLa Jolla, California, 92093, United States
-
University of Maryland, Greenebaum Comprehensive Cancer Center
RECRUITINGBaltimore, Maryland, 21201, United States
-
Xcancer (Urology Cancer Center)
RECRUITINGOmaha, Nebraska, 68130, United States
Conditions
Explore the condition pages connected to this study.